ImmunoTherapy Bridge 2023

 

ImmunoTherapy Bridge 2023
P

Best of SITC 2023 for Clinical Development and IO Trials

By ImmunoTherapy Bridge 2023 FEATURING Paolo A. Ascierto
By ImmunoTherapy Bridge 2023 FEATURING Paolo A. Ascierto
79 views
January 11, 2024
0 Comments
Login to view comments. Click here to Login
Videos
15:37
ImmunoTherapy Bridge 2023

What’s New in NSCLC & Mesothelioma Immunotherapy

Feat. A. Morabito
16:18
ImmunoTherapy Bridge 2023

Innovating Immunotherapy for Pancreatic Cancer

Feat. G. Lesinski
16:54
ImmunoTherapy Bridge 2023

Immunoscore vs. Gene Signature - PRO Immunoscore

Feat. J. Galon
15:09
ImmunoTherapy Bridge 2023

Best of SITC 2023 for Clinical Development and IO Trials

Feat. P. A. Ascierto
20:06
ImmunoTherapy Bridge 2023

Bispecific vs. Combination Therapy - PRO Combination Therapy

Feat. A. Patnaik
11:26
ImmunoTherapy Bridge 2023

Bispecific vs. Combination Therapy - PRO Bispecific

Feat. J. Gulley
14:18
ImmunoTherapy Bridge 2023

Neo-Antigens vs. Alternative Antigens - PRO Neo-Antigens

Feat. S. Schoenberger
12:21
ImmunoTherapy Bridge 2023

Immunotherapy for HCC: Current Status & Future Perspectives

Feat. P. Federico
17:45
ImmunoTherapy Bridge 2023

Activating Innate Immunity in Prostate Cancer: From Bedside-to-Bench…

Feat. A. Patnaik
13:30
ImmunoTherapy Bridge 2023

Surviving in the Lymphoma Microenvironment: A Tough Challenge for CA…

Feat. M. Ruella
16:02
ImmunoTherapy Bridge 2023

Novel Insights Into the Mechanisms of Radiation-Induced Anti-Tumor I…

Feat. S. Demaria
17:25
ImmunoTherapy Bridge 2023

New Developments in Immunotherapy for Ovarian Cancer

Feat. A. Odunsi
18:55
ImmunoTherapy Bridge 2023

Immunotherapy in GI Cancer: Current Treatment Landscape and Challeng…

Feat. A. Avallone
13:53
ImmunoTherapy Bridge 2023

IO Combinations in aRCC: New Achievements and Challenges

Feat. R. Iacovelli
15:39
ImmunoTherapy Bridge 2023

Neoadjuvant IO: Non-Melanoma Skin Cancer

Feat. N. Gross
15:03
ImmunoTherapy Bridge 2023

Spatial Omics in Immunotherapy Trials: Unpacking the Challenges

Feat. C. Bifulco
15:54
ImmunoTherapy Bridge 2023

Non-Melanoma Skin Cancers

Feat. P. A. Ascierto
15:22
ImmunoTherapy Bridge 2023

Engage, Expand, Enable: Combination IO Strategy for Cold Tumors

Feat. J. Gulley
13:20
ImmunoTherapy Bridge 2023

IO in Metastatic Non-Oncogene Addicted NSCLC: Consolidated Options t…

Feat. A. Morabito
14:18
ImmunoTherapy Bridge 2023

How Immunotherapy Changed the Treatment Story for Endometrial and Ce…

Feat. M. Bartoletti
15:40
ImmunoTherapy Bridge 2023

Updates on Radiation and Immunotherapy

Feat. S. Formenti